Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Theoretical mean number of injections per year based on monthly ... Comparison of Age-Related Macular Degeneration Treatment Trials; IVAN: A Randomized Controlled Trial of Alternative Treatments ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

A specialty pharmacy company agreed to a $1.67 million settlement that it gave inventory management systems to retina ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced ...

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...

They can perform tests like optical coherence tomography (OCT) and recommend treatments such as lifestyle adjustments, vitamins, or medical interventions like injections to help preserve vision. At ...